OmniAb, Inc.
A technology platform for therapeutic antibody discovery using transgenic animals.
OABIW | US
Overview
Corporate Details
- ISIN(s):
- KYG072471025 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 5980 HORTON STREET, 94608 EMERYVILLE
- Website:
- https://www.omniab.com/
Description
OmniAb, Inc. provides a technology platform for therapeutic antibody discovery, licensing its technologies to the pharmaceutical industry, biotechnology companies, and academic institutions. The company's core offering is a suite of proprietary and clinically validated transgenic animal platforms engineered to generate diverse repertoires of high-quality, fully human antibodies. A key technology is the Omni_dAb_ platform, which utilizes the first transgenic chicken to produce humanized single-domain antibodies, enabling recognition of highly conserved antigens. The platform is complemented by high-throughput screening technologies, such as the xPloration system, to facilitate the identification and development of next-generation therapeutics. OmniAb's modular and scalable solutions support partners throughout the drug discovery process.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all OmniAb, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OmniAb, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OmniAb, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
